Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora.

  • 2001-12
  • FEMS Immunology & Medical Microbiology 32(1)
    • G. Reid
    • G. Reid
    • D. Beuerman
    • C. Heinemann
    • A. Bruce

Study Design

Type
Randomized Controlled Trial (RCT)
Sample size
n = 42
Population
Healthy women
Methods
Randomized Controlled Trial
  • Highly Cited

Abstract

Forty-two healthy women were randomized to receive one of three encapsulated Lactobacillus rhamnosus GR-1 plus Lactobacillus fermentum RC-14 probiotic dosage regimens or L. rhamnosus GG by mouth each day for 28 days. However, the vaginal flora, assessed by Nugent scoring, was only normal in 40% of the cases, and 14 patients had asymptomatic bacterial vaginosis. Treatment with L. rhamnosus GR-1/L. fermentum RC-14 once and twice daily correlated with a healthy vaginal flora in up to 90% of patients, and 7/11 patients with bacterial vaginosis converted to normal or intermediate scores within 1 month. Ingestion of L. rhamnosus GG failed to have an effect. This study confirms the potential efficacy of orally administered lactobacilli as a non-chemotherapeutic means to restore and maintain a normal urogenital flora, and shows that over 10(8) viable organisms per day is the required dose.

Research Insights

Back to top